Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform disorder
- People whose illness has lasted for 6 months or longer
- People who have significant "negative symptoms" (such as reduced motivation, emotion, or speech — confirm with trial site for specifics)
- People who have been on a stable medication plan for at least 4 weeks before the study begins
- People whose symptoms (both positive and negative) have been considered stable by their treating clinician for at least 3 months
- People who are able to give informed consent to participate
- People who are able to have an MRI scan
Who may not be able to join:
- People who are pregnant, breastfeeding, or using an intrauterine device (IUD)
- People who have had electroconvulsive therapy (ECT) within the past 6 months
- People who have used alcohol or other substances (apart from cannabis) during the week of treatment or within 24 hours before a brain scan
- People who have medical reasons that make a type of brain stimulation called TMS unsafe for them (confirm with trial site for specifics)
- People who have previously received a treatment called rTMS (repetitive transcranial magnetic stimulation)
- People who have a documented history of significant intellectual disability
- People whose primary diagnosis is a psychotic disorder caused by a medical condition or by substance use
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Avolition/Apathy Subscale Score; Change in Scale for the Assessment of Negative Symptoms Total Score; Change in Brief Negative Symptom Scale Total Score; Effect of Targeting Method on Negative Symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.